Functional and Regulatory Studies of Cytochrome c Oxidase Assembly Factor 6 by Pratt, Anthony Thomas
  
 
 
FUNCTIONAL AND REGULATORY STUDIES OF CYTOCHROME C 
OXIDASE ASSEMBLY FACTOR 6 
 
 
A Thesis 
by 
ANTHONY THOMAS PRATT  
 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
 
MASTER OF SCIENCE 
 
 
Chair of Committee,  Vishal M. Gohil  
Committee Members, William Park 
 Gary Kunkel 
Head of Department, Gregory Reinhart  
 
August 2015 
 
 
Major Subject: Biochemistry 
 
Copyright 2015 Anthony Thomas Pratt
  ii  
 
ABSTRACT 
 
The mitochondrial respiratory chain (MRC) consists of four multi-protein complexes in 
the inner membrane of mitochondria and is the main site of cellular respiration. MRC 
biogenesis is facilitated by several assembly factors, many of which remain unidentified 
and uncharacterized. Using an integrative genomic approach, we recently identified an 
evolutionarily conserved role of a previously uncharacterized mitochondrial protein, 
Coa6, in the assembly of MRC complex IV, also known as cytochrome c oxidase (CcO). 
Follow-up experiments showed that the CcO assembly defect could be rescued by 
copper supplementation, implicating Coa6 in mitochondrial copper metabolism. 
However, the precise molecular function of Coa6 in CcO assembly remained unknown. 
To understand the function and regulation of Coa6, we have purified Coa6 to 
homogeneity and generated a polyclonal antiCoa6 antibody, which was used to study 
Coa6 regulation under different nutrient, chemical, and genetic perturbations. By 
measuring Coa6 protein levels under these perturbations, we found that like Cox2, a 
copper containing subunit of CcO, Coa6 is regulated by copper abundance, further 
supporting its role in copper delivery to CcO.  In order to place Coa6 in the CcO copper 
delivery pathway, we performed a genetic epistasis analysis and found synthetic lethal 
interactions between Coa6 and Sco2, a well-known mitochondrial copper 
metallochaperone, and Coa6 and Cox12, a known subunit of CcO. These results suggest 
overlapping but non-redundant roles of Coa6, Cox12 and Sco2 in copper delivery to 
Cox2.  
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NOMENCLATURE 
 
CcO Cytochrome c oxidase 
Coa6 Cytochrome c oxidase assembly factor 6   
IM Inner membrane   
IMS Intermembrane space 
MRC Mitochondrial respiratory chain 
WT Wild type  
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CHAPTER I  
INTRODUCTION  
 
Cytochrome c oxidase (CcO) is the terminal enzyme of the mitochondrial respiratory 
chain (MRC), a system of four electron-transport complexes present in the inner 
membrane (IM) of the mitochondria. Together, the four complexes of the MRC generate 
a proton gradient, which is harnessed by ATP synthase to produce mitochondrial ATP. 
CcO is an evolutionarily conserved enzyme that consists of 13 polypeptides in addition 
to several cofactors, including two copper centers (CuA and CuB), two heme groups 
(heme a and a3), and a magnesium and zinc ion (1). The assembly of CcO is highly 
complex and is not completely understood. To date, approximately 40 CcO assembly 
factors have been discovered, but for many of them their precise role in CcO biogenesis 
remains unclear (2). Elucidating the function of these uncharacterized assembly factors 
is not only crucial for understanding the biogenesis of CcO, but also has biomedical 
significance, since mutations in several of these CcO assembly factors result in 
monogenic mitochondrial diseases (3).  
 
Recently, we identified a novel CcO assembly factor, Coa6, as an evolutionarily 
conserved intermembrane space (IMS) protein essential for assembly of the CcO (4). 
Studies in our lab using a knockout model in yeast and knockdown models in human cell 
lines and zebrafish embryos confirmed that Coa6 is essential for CcO assembly and 
mitochondrial respiration (4). Furthermore, our work and a subsequent study showed 
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that the mutations reported in human COA6 (C1orf31) are pathogenic and result in 
mitochondrial disorder characterized by hypertrophic cardiomyopathy (4,5).  
 
Coa6 contains a conserved Cx9CxnCx10C motif, which is similar to a twin Cx9C motif 
found in mitochondrial IMS proteins involved in copper delivery to CcO. Both of the 
reported Coa6 disease patients had mutations within this motif (4-6). Multiple twin Cx9C 
motif-containing IMS proteins, such as Cox11, Cox17, Cox19, Cox23, Sco1, Sco2, and 
Cmc1 have been shown to be involved in copper delivery to CcO (7), but the exact 
sequence of these proteins in the copper delivery pathway remains unclear. The addition 
of exogenous copper to growth media is able to rescue the respiratory deficient growth 
of cox17Δ and cmc1Δ cells (8,9), and likewise, copper is able to fully restore growth of 
coa6Δ yeast (4). This result strongly implicates Coa6 in copper delivery to CcO, 
possibly as a metallochaperone. Coa6 has all the features of a CcO copper 
metallochaperone in that it contains a conserved cysteine-rich motif, it is localized to the 
IMS, and exogenous copper is able to rescue CcO assembly defect in coa6Δ. Despite 
these observations, however, the exact molecular function of Coa6 remains unknown.  
 
Due to its clinical significance in mitochondrial disease pathogenesis, evolutionary 
conservation, and lack of assigned function, I have undertaken a detailed study of the 
function and regulation of Coa6 in the yeast Saccharomyces cerevisiae. S. cerevisiae 
serves as a useful model to study Coa6 because three of the four MRC complexes are 
conserved, which suggests that essential assembly factors are also conserved. 
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Additionally, yeast are able to proliferate using different carbon sources as fuel to 
generate ATP by using either glycolysis or mitochondrial respiration. Mitochondrial 
biogenesis and respiration is stimulated in respiro-fermentative and non-fermentative 
media containing galactose and glycerol/ethanol, respectively, providing an optimal 
growth conditions to study the function of a mitochondrial protein (10). Additionally, 
mitochondrial biogenesis is regulated by the availability of copper to the media, such 
that transcription of mitochondrial proteins is downregulated under copper limiting 
conditions (11). Since these nutritional perturbations are well characterized in the yeast,  
I have been able to study the regulation of Coa6 under these conditions.  
 
Using an antibody against native Coa6 protein, I show that Coa6 is regulated by carbon 
source, growth phase, and copper availability, further implicating Coa6 in CcO 
assembly. A genetic interaction study discovered a synthetic lethal interaction between 
Coa6 and Sco2, a well-known mitochondrial copper metallochaperone, under respiratory 
growth conditions. I found that simultaneous deletion of Coa6 and Sco2 results in a 
complete loss of Cox2, thus providing biochemical basis for the synthetic lethal 
interaction. Interestingly, this phenotype could not be rescued by copper suggesting that 
these two proteins act in parallel pathway of copper delivery to CcO. Unexpectedly, a 
similar synthetic lethal interaction was also uncovered between Coa6 and Cox12, one of 
the core subunits of CcO. Taken together, these results firmly place Coa6 in copper 
delivery pathway to CcO and suggest an overlapping but non-redundant role of Coa6, 
Sco2 and Cox12 in CcO biogenesis.  
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CHAPTER II  
PURIFICATION OF COA6  
 
Pure Coa6 is necessary to ascertain copper binding and coordination, determine its 
structure, identify interacting partners, assign specific biochemical activity and generate 
antibody that specifically recognizes the native protein in its host organism. Therefore, I 
purified Coa6 and here I describe the purification scheme used to purify Coa6 for the 
purpose of antibody generation.  
 
Materials and Methods 
 
Coa6 expression and purification 
 
The yeast COA6 was first subcloned into a pET28a-His6-GFP-TEV vector using EcoRI 
and XhoI restriction sites. This construct was then transformed into Rosetta DE3 
Escherichia coli cells to express recombinant Coa6. Briefly, transformed cells were 
grown in LB medium supplemented with 25 µg/mL chloramphenicol and 50 µg/mL 
kanamycin at 37ᴼC till A600 of 0.5. Protein expression was then induced with 0.5 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) for 16 hours at 18ᴼC. The cells were 
pelleted at 5,000g for 15 minutes and resuspended in lysis buffer (50 mM Tris-HCl, pH 
7.5, 500 mM NaCl, and 10% glycerol) with protease inhibitor cocktail (Roche 
Diagnostic). The cells were lysed using a sonic dismembrator (Fisher Scientific) and cell 
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debris were pelleted at 16,000g for 30 minutes at 4ᴼC. The supernatant was passed 
through a HisTrap™ HP column (GE Healthcare Life Sciences) and washed with 20 
column volumes of washing buffer (50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 10% 
glycerol, and 50 mM imidazole). The fused protein was eluted using 5 column volumes 
of elution buffer (50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 10% glycerol, and 500 mM 
imidazole). The imidazole concentration of the eluent was diluted to 50 mM using lysis 
buffer immediately prior to the addition of recombinant His6-Tobacco Etch Virus (TEV) 
protease at a ratio of 1 mg TEV protease per 4 mg fused protein. TEV-catalyzed 
digestion of Coa6 fusion protein was performed for 4 hours at room temperature in the 
presence of 5 mM DTT. The digested sample was then passed through a second 
HisTrap™ HP column to bind His6-GFP and TEV. Isolated Coa6 protein was collected 
and passed through a Superdex 200 10/300 FL column (GE Healthcare Life Sciences) to 
separate Coa6 from residual His6-GFP and TEV that failed to bind to the HisTrap™. At 
each step, protein purity and quantity were assessed by SDSPAGE with Coomassie stain 
and Bradford assay, respectively.  
 
Generation of Coa6 antibody 
 
1.5 mg of pure Coa6 protein was sent to Rockland™ Antibodies & Assays for antibody 
generation. Coa6 antibody was purified from rabbit antisera by incubating the sera with 
Coa6 protein coupled to Affi Gel 10 beads (Biorad) in a 5 mL Qiagen column for 2-4 
hours at room temperature. The column was washed using 50-100 mL PBS. Pure 
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polyclonal antibody was eluted using acid buffer (0.2 M glycine, 500 mM NaCl, pH 2.0) 
into a conical tube containing 1.5 M Tris (pH 8.8) to neutralize the pH. Purified antibody 
was aliquoted and stored at -20ᴼC. 
 
Whole cell yeast protein extraction 
 
Yeast cells were cultured at 30ᴼC in 7.5 mL of YPGE (1% yeast extract, 2% 
bactopeptone, 3% glycerol and 1% ethanol) till mid-logarithmic phase and were pelleted 
by centrifugation at 3,000g for 5 minutes at 4ᴼC. The cell pellet (~75 mg) was washed 
with water and resuspended in 350 µL SUMEB buffer (10 mM MOPS, pH 6.8, 8 M 
urea, 10 mM EDTA, 1.0% SDS) containing 1 mM PMSF and protease inhibitor cocktail 
(Roche Diagnostic) and transferred to a 2 mL tube containing 350 mg of acid-washed 
glass beads (Sigma-Aldrich). Cells were vortexted for 1 minute followed by 30 seconds 
on ice. This procedure was repeated three times. Lysed cells were kept on ice for 10 
minutes to reduce bubbles and then transferred to 70ᴼC for 10 minutes. Cell debris and 
glass beads were spun down at 14,000g for 10 minutes at 4ᴼC. The supernatant was 
transferred to a separate tube and protein was measured by BCA assay (Life 
Technologies). 
 
SDSPAGE and Western blotting 
 
50 µg of yeast whole cell protein lysate was separated on 12% Bis-Tris NUPAGE gels  
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 (Life Technologies) and blotted onto a polyvinylidene difluoride (PVDF) membrane. 
Membranes were blocked for 1 hour in 5% nonfat milk dissolved in Tris-buffered saline 
with 0.1% Tween20 (TBST-milk). Membranes were incubated with primary antibody in 
TBST-milk overnight at 4ᴼC. Primary antibodies were used at the following dilutions: 
Coa6, 1:1,000; Porin, 1:50,000 (Abcam 110326). Secondary antibodies were used at a 
1:5,000 dilution in TBST-milk for 1 hour at room temperature. Membranes were 
developed using WesternLightning Plus-ECL (PerkinElmer) or SuperSignal West Femto 
(Thermo Scientific).  
 
 
 
 
Figure 1. Coa6 purification scheme. 
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Results 
 
Purification of Coa6 
 
Coa6 with a His6-GFP-TEV tag and Rosetta DE3 expression system were chosen for 
large-scale protein purification as described in Materials and Methods and illustrated in 
Fig. 1. GFP increased the solubility of the fusion construct and provided a visual means 
 
Figure 2. Purification of Coa6 from E.coli. (A) E.coli Rosetta DE3 cells 
overexpressing a fusion protein His6-GFP-TEV-Coa6 were sonicated (CL) and 
centrifuged to pellet cellular debris. The supernatant (S) was passed through a 
HisTrap™ HP column and the purified fraction (E1) was subjected to TEV 
proteolysis for 4 hours at room temperature (TEV). The solution was passed 
through a second HisTrap™ HP column. Both the flow through (FT) and wash 
(W) were collected. Elution of the column revealed all Coa6 had eluted in the 
flow through and wash (E2). The flow through and wash were pooled together and 
concentrated to ~2 mL (FT+W). (B) Purified Coa6 after passing through Superdex 
200 10/300 FL column. Molecular weight (MW) markers (in kilodaltons) and the 
positions of individual proteins are indicated.  
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of determining expression and location of the fusion protein throughout the purification 
process. Protease inhibitors were present during cell lysis to prevent premature cleavage 
of the fusion protein, but cleaved His6-GFP and Coa6 can nevertheless be detected 
following elution from the first HisTrap™ HP column (Fig. 2A, lane E1). Addition of 
TEV protease cleaved the fusion protein, releasing Coa6 and allowing it to pass through 
a second HisTrap™ HP column in the flow through and wash (Fig. 2A, lanes FT and 
W). When both fractions were combined and concentrated, residual TEV protease was 
detected (Fig.2A, lane FT+W). Therefore, the flow through + wash was subjected to size 
exclusion chromatography by injecting onto a Superdex 200 10/300 FL column to 
remove these residual contaminants (Fig. 2B). A total yield of 1 mg pure Coa6 per 1 L of 
bacterial culture was obtained.    
 
Purified Coa6 antibody specifically recognizes yeast Coa6 
 
Polyclonal antibody was produced and purified from rabbit sera as explained in 
Materials and Methods. To confirm the specificity of our antibody, I probed for Coa6 
levels in yeast wild type (WT), coa6Δ, and coa6Δ transformed with a multi-copy 
pRS426 plasmid expressing COA6. Cells were grown in YPGE to mid-logarithmic 
growth phase. Coa6 knockout cells were supplemented with 5 µM copper chloride 
(CuCl2) to allow for equivalent growth. I observed a band in WT cells at ~12 kDa, which 
corresponds with the molecular weight of Coa6 (Fig. 3). The same band was absent in 
coa6Δ cells, but was present at a higher intensity in the same position in cells 
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overexpressing native Coa6, confirming the identity of Coa6. The lack of other 
additional high-intensity bands suggests high specificity of our antibody, making it a 
useful resource to study regulation of Coa6 in yeast cells (Fig. 3).  
  
 
Figure 3. Validation of Coa6 antibody. Yeast 
whole cell protein was extracted from WT, 
coa6Δ, and coa6Δ transformed with pRS426-
COA6 grown in YPGE liquid medium to mid-
logarithmic growth phase. coa6Δ cells were 
grown in the presence of 5 µM CuCl2. 50 µg 
of whole cell protein was loaded on a 12% 
Bis-Tris gel and analyzed using 
SDSPAGE/Western blot. Top panel: Western 
blot using purified polyclonal Coa6 antibody. 
The position of Coa6 is indicated. Bottom 
panel: Por1 was used as a loading control. 
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CHAPTER III  
ANALYSIS OF COA6 REGULATION AND FUNCTION 
 
In order to further study the role of Coa6 in copper transport to CcO, it is necessary to 
identify the growth conditions and factors that regulate Coa6 levels in yeast cells. 
Identifying Coa6 regulatory factors will not only provide valuable insights into its 
function but will also allow us to optimize future experiments directed at analyzing Coa6 
function in vivo by determining when Coa6 is most abundant. With this goal, we tested 
the effect of different growth conditions, nutrients, copper abundance and the presence 
of mitochondrial CcO assembly factors on Coa6 expression. 
 
Materials and Methods 
 
Yeast strains and culture conditions 
 
All strains used were obtained from Open Biosystems or independently created in the 
Gohil lab (Table 1). For growth in liquid medium, yeast cells were precultured in YPD 
(1% yeast extract, 2% peptone, and 2% glucose) at 30°C and later inoculated into YPD 
media or media containing 2% galactose (YPGal) or 3% glycerol + 1% ethanol (YPGE). 
Growth measurements were done either by measuring optical density of liquid growth 
cultures using a DU® 730 UV/Vis Spectrophotometer (Beckman Coulter) or by seeding 
serially diluted cells on solid medium. The cell number of overnight precultures was 
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calculated with a hemocytometer prior to being serially diluted at 10
4
, 10
3
, 10
2
, and 10
1
 
cells per 3 μl. Dilutions were spotted onto plates containing different media as indicated and 
incubated at 30°C for 3 days. 
 
 
 
 
  
Table 1. 
Yeast strains used in this study. 
Strain Genotype Source 
BY4742 WT MAT α his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Open Biosystems  
BY4742 coa6Δ Mat α, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, 
coa6Δ:: NatMX4 
Gohil lab 
BY4741 WT Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Open Biosystems  
coa6Δ Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
coa6Δ:: KanMX4 
Open Biosystems  
sco1Δ Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
sco1Δ::KanMX4  
Open Biosystems  
sco2Δ Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
sco2Δ::KanMX4  
Open Biosystems 
cox11Δ Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
cox11Δ::KanMX4  
Open Biosystems 
cox12Δ Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
cox12Δ::KanMX4  
Open Biosystems 
cox17Δ Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
cox17Δ:: HphMX4 
Gohil lab 
cox19Δ Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
cox19Δ::KanMX4  
Open Biosystems 
cox23Δ Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
cox23Δ::KanMX4  
Open Biosystems 
cmc1Δ Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
cmc1Δ::KanMX4  
Open Biosystems 
cmc2Δ Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
cmc2Δ::KanMX4 
Open Biosystems 
cmc3Δ Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
cmc3Δ::KanMX4  
Open Biosystems 
STY3 
(cox12Δcoa6Δ) 
Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
lys200, met1500, cox12Δ::KanMX4, 
coa6Δ::clonNAT  
Gohil lab 
STY10 
(sco2Δcoa6Δ) 
Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, 
sco2Δ::KanMX4, coa6Δ::clonNAT  
Gohil lab 
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Whole cell yeast protein extraction and isolation of mitochondrial fractions 
 
Yeast cells (60-80 mg wet weight) were suspended in 350 µL SUMEB buffer (10 mM 
MOPS, pH 6.8, 8 M urea, 10 mM EDTA, 1.0% SDS) containing 1 mM PMSF and 
protease inhibitor cocktail (Roche Diagnostic). Cell were transferred to a fresh tube 
containing 350 mg of acid-washed glass beads (Sigma-Aldrich) and were vortexted three 
times for 1 minute each, with 30 seconds incubation on ice between every vortex step. 
Lysed cells were kept on ice for 10 minutes to reduce bubbles and then heated to 70ᴼC 
for 10 minutes. Cell debris and glass beads were spun down at 14,000g for 10 minutes at 
4ᴼC.  The supernatant was transferred to a separate tube and protein was quantified by 
BCA assay (Life Technologies). Mitochondria were isolated from yeast cells grown to 
early stationary growth phase in YPD by a previously described method (12). 
 
SDSPAGE and Western blotting  
 
Whole cell yeast protein lysate was fractionated by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDSPAGE) using precast 12% Bis-Tris gels and 
blotted onto a polyvinylidene difluoride (PVDF) membrane. Membranes were blocked 
for 1 hour in 5% nonfat milk dissolved in Tris-buffered saline with 0.1% Tween20 
(TBST-milk), followed by incubation with primary antibody in TBST-milk overnight at 
4ᴼC. Primary antibodies were used at the following dilutions: Coa6, 1:1,000; Cox1, 
1:10,000 (Abcam 110270); Cox2, 1:10,000 (Abcam 110271); Cox17, 1:250 (from Dr. 
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Alexander Tzagoloff); Cmc1, 1:500 (from Dr. Antoni Barrientos); HA, 1:10,000 (Sigma 
H9658); Porin, 1:50,000 (Abcam 110326); Pgk1, 1:50,000 (Life Technologies 459250).  
 
Results 
 
Coa6 is regulated by mitochondrial biogenesis factors 
 
Previous studies have shown that growth phase and carbon source regulate 
 
Figure 4. Coa6 is regulated by mitochondrial biogenesis factors. WT 
yeast were precultured in YPD and inoculated in fresh YPD, YPGal, 
or YPGE liquid media at 30ᴼC with a starting A600 of 0.1. Cells were 
grown to early logarithmic (EL), mid-logarithmic (ML), and early 
stationary (ES) growth phase in each media and whole cell protein 
was extracted. Coa6 was analyzed alongside Cox2 by Western 
blotting. Porin (Por1) was used as a loading control.  
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mitochondrial biogenesis (10,13). Therefore, I hypothesized that Coa6, being a 
mitochondrial protein required for MRC complex IV biogenesis, could be regulated by 
factors that promote mitochondrial biogenesis. To test this hypothesis, steady state levels 
of Coa6 were determined in WT yeast cells grown in fermentable (YPD), respiro-
fermentable (YPGal), or non-fermentable (YPGE) liquid media at early logarithmic 
(EL), mid-logarithmic (ML), or early stationary (ES) growth phases. As seen in Fig. 4, 
Coa6 levels were highest in respiro-fermentable and non-fermentable media, indicating 
Coa6 is regulated by carbon source. Additionally, expression levels of Coa6 increase 
with growth phase in fermentable media, but decrease in non-fermentable media, 
demonstrating that Coa6 levels depend on growth phase. Interestingly, increase in Coa6 
levels precedes those of Cox2, one of the copper containing subunits of CcO, suggesting 
that Coa6 must be present for optimal expression of Cox2. 
 
Coa6 levels decrease in response to copper deprivation 
 
A recent study has shown that iron-containing proteins of the MRC, specifically MRC 
complex I, MRC complex III, and cytochrome c, decrease in response to increasing 
amounts of iron chelator deferoxamine (DFO) in mouse muscle cells (14). Since Coa6 
has been implicated in the copper delivery pathway to CcO, I hypothesized that Coa6 
levels would alter in response to copper chelation and supplementation. In order to 
identify optimal concentration of copper-specific chelator bathocuproinedisulfonic acid 
(BCS) and copper, WT yeast were grown in YPGE and YPGal with increasing amounts 
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Figure 5. Copper deprivation retards yeast growth under respiratory growth 
conditions. WT yeast were precultured in YPD and inoculated in either fresh (A) 
YPGE or (B) YPGal liquid media with increasing amounts of BCS and CuCl2 at 
30ᴼC with a starting A600 of 0.1. Growth was analyzed by measuring absorbance 
at 600 nm. 
of BCS or copper chloride (CuCl2). An increasing amount of BCS is expected to deprive 
yeast cells of bioavailable form of copper and therefore would reduce copper containing 
MRC complex IV, leading to diminished growth in conditions that require mitochondrial 
ATP synthesis. As expected, increasing amounts of BCS severely reduced yeast growth 
in YPGE media, whereas additional copper supplementation to the media promoted 
yeast growth (Fig. 5A). A similar but less severe pattern can be seen when cells are 
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grown in a respiro-fermentative conditions in YPGal medium (Fig. 5B). Therefore, in 
order to work with equivalent amounts of cells, I chose to probe for Coa6 levels in 
YPGal media supplemented with BCS and CuCl2. Coa6 levels decreased with increasing 
BCS addition, whereas copper supplementation appears to increase Coa6 levels (Fig. 
6A). In a similar fashion, Cox2 levels decrease drastically under copper limiting 
conditions, while copper supplementation slightly increases Cox2 (Fig. 6A). Therefore, 
Coa6 and Cox2 follow a similar pattern in response to altering levels of copper in the 
environment. In contrast, Cox17, a known metallochaperone that transfers copper to 
Cox11 and Sco1 (15), remains constant regardless of copper availability in the media 
 
Figure 6. Coa6 levels are dependent on copper availability. (A) Western blot 
analysis of whole cell protein lysate prepared from WT yeast cells grown to 
mid-logarithmic growth phase in YPGal medium with increasing amounts of 
BCS or CuCl2.(B) Western blot analysis of mitochondria isolated from WT 
cells grown in YPD to early stationary growth phase with increasing amounts 
of BCS. Por1 and Pgk1 were used as loading controls. 
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(Fig. 6A). The decrease in Coa6 with BCS supplementation is more obvious in 
mitochondrial samples isolated from chromosomally tagged-Coa6 cells (Fig. 6B). As 
expected, Cox1 and Cox2 the copper containing subunits of CcO, also decreases with 
increasing BCS (Fig. 6B). Interestingly, Cmc1, a copper-binding CcO assembly factor, 
also decreases with increasing amounts of BCS in isolated mitochondria (Fig. 6B).  
 
Coa6 expression is independent of other IMS CcO assembly factors 
 
Previous reports (4,9) have shown that exogenous copper supplementation can overcome 
the deletion of CcO assembly factors, like Coa6, Cox17, and Cmc1, suggesting that 
parallel pathways of copper delivery to CcO exist, and that the protein of one pathway 
 
Figure 7. Coa6 expression is independent of mitochondrial CcO assembly 
factors. Whole cell lysate protein was extracted from the indicated knockout 
strains grown in YPGal liquid medium to mid-logarithmic growth phase and 
analyzed by Western blotting with indicated antibodies.  
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may compensate for the lack of the other. For example, Cmc1 levels increase 
significantly in response to deletion of Cmc2, which suggests they share a common 
function (16). To explore the possibility that Coa6 levels may be regulated by other CcO 
assembly factors implicated in copper delivery pathway, I probed for Coa6 levels in 
various knockout strains of known copper metallochaperones (Cox11, Cox17, Cox19, 
Cox23, Sco1, and Sco2 (7)) and twin Cx9C motif containing proteins implicated in CcO 
assembly (Cmc1  (9), Cmc2 (16), and Cmc3 (17)). Overall, Coa6 levels remain constant 
despite the deletion of the CcO assembly factors tested (Fig. 7), suggesting that Coa6 
abundance is independent of the presence of other CcO assembly factors.  
 
Coa6 works in conjunction with Sco2 and Cox12 to maintain Cox2 levels 
 
In order to place Coa6 in the CcO copper delivery pathway, a genetic epistasis study was 
performed, where coa6Δ cells were crossed with the deletion strains of each of the known 
copper metallochaperones and Cx9C proteins implicated in CcO assembly. The resulting 
double knockouts were extensively phenotyped in different growth media, temperatures, 
and copper supplementations. Analysis of the growth phenotypes of both the parent 
knockouts and double knockout revealed that coa6Δsco2Δ is synthetic lethal when grown on 
non-fermentable media (YPGE) (Fig. 8A). Additionally, coa6Δcox12Δ is also synthetic 
lethal when grown on complete synthetic respiro-fermentable media (CS Galactose) (Fig. 
8B). Exogenous copper fails to rescue the growth defect of either double knockout (Fig. 8A-
B) suggesting that these proteins are acting in parallel pathways. Sco2 is a mitochondrial 
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inner membrane bound copper metallochaperone that extends into the IMS and has been 
suggested to act as an oxidoreductase in human cells (18,19), while Cox12 is a subunit of 
CcO itself whose biochemical function is unknown (20). The synthetic lethal interaction of 
Coa6 with Sco2 is not surprising since prior evidence for their involvement in CcO copper 
 
Figure 8. Coa6, Sco2 and Cox12 have overlapping functions in CcO assembly. (A) 
Serially diluted WT, coa6Δ, sco2Δ, and coa6Δsco2Δ cells were spotted on YPGE 
plates with and without 5 µM CuCl2 at 30ᴼC. (B) Serially diluted WT, coa6Δ, 
cox12Δ, and coa6Δcox12Δ cells were spotted on synthetic complete (SC) galactose 
with and without 5 µM CuCl2 at 30ᴼC. (C-D) WT, single knockouts of Coa6, Sco2, 
Cox12, and coa6Δsco2Δ and coa6Δcox12Δ double knockouts were grown to mid-
logarithmic phase in YPGal liquid medium with and without 5 M CuCl2 at 30ᴼC. 
Protein was extracted from whole cells and analyzed by Western blot. Por1 and 
Pgk1 were used as loading controls.  
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delivery pathway was available, but the synthetic lethal interaction between Coa6 and Cox12 
is surprising, and it suggests a hitherto undiscovered role of Cox12 in copper delivery to 
CcO subunits. To probe for the mechanism that leads to synthetic lethality of double 
knockouts, I analyzed levels of the copper containing CcO subunit Cox2. As seen in Fig. 
8C-D, Cox2 levels are decreased in coa6Δ, sco2Δ, and cox12Δ to different degrees but in 
both coa6Δsco2Δ and coa6Δcox12Δ, Cox2 is completely absent. Exogenous copper fails to 
restore Cox2 levels in both double knockouts (Fig. 8C-D). Coupled with the growth data, the 
lack of Cox2 in coa6Δsco2Δ and coa6Δcox12Δ suggests that Coa6 has an overlapping 
function with Cox12 and Sco2 to maintain Cox2 levels. 
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CHAPTER IV  
SUMMARY AND CONCLUSIONS  
 
Recent studies in our lab identified Coa6 as an evolutionarily conserved CcO assembly 
factor in yeast, zebrafish, and humans. Coa6 sequence features, submitochondrial 
localization and metal supplementation experimentation suggested its role in 
mitochondrial copper metabolism; however, its precise role in CcO copper delivery 
pathway remained unknown.  In an effort to uncover its function in CcO assembly, I 
present the first purification scheme for yeast Coa6 protein. Purified Coa6 was used to 
generate a polyclonal antibody, which I employed to study its regulation and found that 
Coa6 is regulated by carbon source, growth phase, and copper abundance, all of which 
implicated Coa6 in the mitochondrial copper delivery pathway to CcO. A genetic 
epistasis experiment placed Coa6 in the copper delivery pathway and suggested its 
overlapping function with Sco2, a well-known mitochondrial copper metallochaperone, 
and Cox12, a subunit of CcO, in maintaining steady state levels of Cox2. 
 
Because Coa6 is a conserved mitochondrial protein, I first chose to explore if 
mitochondrial biogenesis factors regulate the expression of Coa6. In S. cerevisiae, 
mitochondrial biogenesis is stimulated in galactose-containing respiro-fermentable and 
glycerol/ethanol-containing non-fermentable media, while glucose-containing 
fermentable media causes repression of mitochondrial genes (21). Consistent with this 
observation, I observe that Coa6 levels are higher in respiro-fermentable and non-
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fermentable media than in fermentable media (Fig. 4), indicating Coa6 is regulated by 
carbon source. Likewise, Coa6 displays growth phase dependent regulation, which is 
most obvious in fermentable media, where glucose-mediated catabolite repression is 
released when glucose is consumed by proliferating cells, thereby resulting in 
derepression of mitochondrial genes (including Coa6). Interestingly, in each growth 
condition, increase in Coa6 levels precedes Cox2, suggesting that Coa6 must be present 
for Cox2 expression (Fig. 4). This observation further supports Coa6’s role as a CcO 
assembly factor. 
 
When WT cells are grown under copper limiting conditions through the addition of 
BCS, a decrease in Coa6 levels can be observed (Fig. 6A). Interestingly, CcO assembly 
factor Cmc1 also follows a similar pattern under copper deprivation conditions (Fig. 
6B). Deprivation of copper has the most severe impact on the stability of the copper 
containing subunits of CcO, Cox1 and Cox2, both of which need copper to be 
catalytically active and stably expressed (Fig. 6A-B). A larger decrease in Cox proteins 
and a smaller decrease in the levels of Coa6 can be possibly explained by a scenario in 
which some fraction of Coa6 molecules interacts with Cox2 during Cox2 maturation, but 
the complex is depleted when copper is limiting. Thus, a pool of Cox2-bound Coa6 will 
deplete in copper limiting condition but unbound Coa6 may remain stable. The same 
pattern can explain why Cmc1 levels decrease alongside Cox1, as Cmc1 is essential for 
the synthesis of Cox1 and is part of a high molecular weight complex (9), containing 
Cox1 (22). Additionally, this model explains why Cox17 levels remain unchanged 
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despite copper fluctuations, since Cox17 itself has not been shown to directly interact 
with any of the copper-containing CcO subunits (Fig. 6A).  
 
Exogenous copper supplementation rescues the deletion of Coa6, Cox17, and Cmc1, 
suggesting the possibility that, in contrast to a single, linear pathway of copper delivery 
to CcO, parallel pathways of copper delivery to CcO exist. Therefore, it is likely that the 
proteins involved in these pathways are reciprocally regulated. For example, Cmc1 
levels increase when Cmc2 is deleted, indicating they likely have an overlapping 
function (16). However, unlike Cmc1, Coa6 levels are independent of CcO copper 
metallochaperones (Fig. 7). While it is possible that one of these proteins overexpresses 
to compensate for deletion of Coa6, the lack of available antibodies for these proteins 
makes testing this possibility difficult.  
 
While regulatory studies shed light on the putative function of Coa6, genetic interaction 
studies can provide more direct insight into Coa6’s function. Therefore, a genetic 
interaction study of Coa6 was performed, which uncovered interactions of Coa6 with 
both Sco2 and Cox12 (Fig. 8A-B). These results are strengthened by the fact that Cox2 
levels are completely absent in both double knockouts (Fig. 8C-D), confirming an 
overlapping function of Coa6, Sco2 and Cox12 in Cox2 maturation. While the molecular 
function of Cox12 in CcO biogenesis is not established, mammalian Sco2 has been 
shown to be required for copper metalation of Cox2 (18). These results taken together in 
context of our findings suggest that Coa6, Sco2 and Cox12 play a critical role in the 
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copper delivery pathway to CcO. It would be interesting to see as to what extent these 
proteins share overlapping functions. This can be tested by checking if coa6Δ growth 
defects can be rescued by overexpression of either Sco2 or Cox12 or both. 
 
The biomedical significance of Coa6 has come to light in recent years with the report of 
two separate patients with pathogenic mutations in Coa6 (5,6). Without an ascribed 
function for Coa6, it is extremely difficult to treat diseases that arise from Coa6 
mutations, and both reported patients succumbed to hypertrophic cardiomyopathy. While 
copper supplementation offers an exciting therapuetic option for mitochondrial disease 
patients with mutations in Coa6, many important questions remain about the mechanism 
of this rescue. For instance, what role does Coa6 play in copper delivery to CcO? How 
does Coa6 function alongside Sco2 and Cox12 to maintain mature levels of Cox2? 
Through the purification of Coa6, generation of native antibody, and uncovering the 
regulation of Coa6, I have taken important strides in revealing the exact role of Coa6 in 
the copper delivery pathway for CcO assembly that will guide future experiments to 
address these questions.   
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